Merle Ferguson - 20 Apr 2026 Form 4 Insider Report for BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)

Reporting relationship: Director
Issuer ticker: BFNH
Reported as of: 20 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Sep 2026, 16:09:56 UTC
Prior SEC filing: 18 Oct 2023
Source filing: View source filing
Reporting owner signature: /s/ Merle Ferguson

Key filing fact

Merle Ferguson filed Form 4 for BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) on 02 Sep 2026.

Key facts

This page summarizes Merle Ferguson's Form 4 filing for BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 02 Sep 2026, 16:09.

Change

Previous filing in this sequence was filed on 18 Oct 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001749860 Primary reporting owner

Ferguson Merle

Relationship: Director
Address: 150 BARBARA LANE, ENCINITAS
Signature: /s/ Merle Ferguson
Signature date: 02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BFNH transaction

Common Stock; Par Value $0.001

Gift

Transaction value
Shares: +20,580,000
Change %: +1035%
Price: $0.007000^*
Shares after: 22,568,000
Date: 20 Apr 2026
Ownership: Direct

BFNH transaction

Common Stock; Par Value $0.001

Gift

Transaction value
Shares: +4,132,000
Change %: +18%
Price: $0.001000^*
Shares after: 26,700,000
Date: 20 Apr 2026
Ownership: Direct

BFNH transaction

Common Stock; Par Value $0.001

Sale

Transaction value
Shares: -26,700,000
Change %: -100%
Price: $0.0150^*
Shares after: 0
Date: 22 Apr 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .